Functional studies reveals GEP acts as a growth factor to stimulate proliferation and migration, and confer chemoresistance in many types of cancers including breast cancer [16, 17], ovarian cancer [18, 19], liver cancer [20, 21] and bile duct cancer [22]. This evidence concerns the gene GRN and ovarian carcinoma.